Intriguingly, TGR5 signalling exhibits ​​a stage-dependent duality​​: it ​​exerts hepatoprotective effects​​ during early cholestasis but ​​becomes pro-tumorigenic in established CCA (123). The gene discussed is GPBAR1; the disease is cholangiocarcinoma.